Elsevier

Vaccine

Volume 38, Issue 39, 3 September 2020, Pages 6075-6077
Vaccine

Commentary
Ensuring access and affordability through COVID-19 vaccine research and development investments: A proposal for the options market for vaccines

https://doi.org/10.1016/j.vaccine.2020.07.068Get rights and content

Highlights

  • Currently, unconditional investment is being made into COVID-19 vaccine R&D COVID-19 vaccine R&D investments should also ensure access and affordability.

  • The options market for antibiotics, could be adapted for use with COVID-19 vaccines.

  • This could help fund R&D, boost manufacturing capacity and secure fair prices.

  • Further research on the OMV model in the current COVID-19 crisis is warranted.

Keywords

Covid19
Research and development
Manufacturing capacity
Innovative financing mechanisms
Health policy

Cited by (0)

View Abstract